cytarabine and Eye Diseases

cytarabine has been researched along with Eye Diseases in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braverman, RS; Carlson, I; Liang, X; Petersen, WC; Schlis, KD; Wang, M1
Krema, H; Pavlin, CJ; Santiago, RA; Schuh, A1
Hansen, RM; Heuer, DK; Ritch, PS1
Bishop, JF; Bradstock, K; Cobcroft, R; Enno, A; Fox, R; Garson, OM; Gillett, A; Herrmann, R; Joshua, D; Juneja, S; Lowenthal, RM; Matthews, JP; Page, F; Szer, J; Van Der Weyden, M; Wolf, MM; Young, GA1
Aoyama, T; Chiba, S; Hirai, H; Iga, T; Itoh, M; Kami, M; Kotaki, H; Matsuyama, T; Nakajima, K; Nakamura, K; Saitoh, T; Yamamura, Y; Yazaki, Y1
Assil, KK; Blumenkranz, M; Hartzer, M; Nehorayan, M; Ward, T; Weinreb, RN1
Graves, T; Hooks, MA1
Bauters, F; Fenaux, P; Jouet, JP; Pollet, JP; Simon, M1
Colly, LP; Peters, WG; Swart, W; Willemze, R1
Khwaja, TA; Long, RA; Robins, RK; Sidwell, RW; Simon, LN; Szekeres, GL1
Juel-Jensen, BE1

Trials

2 trial(s) available for cytarabine and Eye Diseases

ArticleYear
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.
    Blood, 1996, Mar-01, Volume: 87, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome

1996
[Effects of the rational use of corticosteroids eye drops for the prevention of ocular toxicity in high-dose cytosine arabinoside therapy].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1999, Volume: 119, Issue:3

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Betamethasone; Cytarabine; Eye Diseases; Female; Glucocorticoids; Humans; Male; Ophthalmic Solutions

1999

Other Studies

9 other study(ies) available for cytarabine and Eye Diseases

ArticleYear
Pseudohypopyon: Extramedullary relapse of acute myelogenous leukemia with poor prognosis.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:7

    Topics: Anterior Chamber; Antimetabolites, Antineoplastic; Cytarabine; Eye Diseases; Female; Humans; Infant; Injections, Spinal; Leukemia, Myelomonocytic, Acute; Neoplasm Recurrence, Local; Prognosis; Suppuration

2009
Cytarabine toxicity of the corneal endothelium.
    Annals of hematology, 2013, Volume: 92, Issue:4

    Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Endothelium, Corneal; Eye Diseases; Humans; Leukemia, Myeloid, Acute; Male; Vision Disorders

2013
Ocular toxicity from high-dose cytosine arabinoside.
    Cancer, 1983, Feb-01, Volume: 51, Issue:3

    Topics: Cornea; Corneal Opacity; Cytarabine; DNA; Drug Administration Schedule; Eye Diseases; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Visual Acuity

1983
Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes.
    Investigative ophthalmology & visual science, 1991, Volume: 32, Issue:11

    Topics: Animals; Cytarabine; Disease Models, Animal; Drug Carriers; Eye Diseases; Half-Life; Liposomes; Rabbits; Retinal Diseases; Uracil Nucleotides; Vitreous Body

1991
Drug-induced toxicities associated with high-dose cytosine arabinoside infusions.
    Pharmacotherapy, 1989, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Central Nervous System Diseases; Cytarabine; Eye Diseases; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Diseases

1989
[Cytosine-arabinoside in high doses in refractory acute granulocytic leukemia. Apropos of 17 cases].
    Nouvelle revue francaise d'hematologie, 1985, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Cytarabine; Drug Resistance; Eye Diseases; Female; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged

1985
[Ophthalmological side effects of the use of cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1985, Dec-28, Volume: 129, Issue:52

    Topics: Cytarabine; Dose-Response Relationship, Drug; Eye Diseases; Humans

1985
Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates.
    Journal of medicinal chemistry, 1972, Volume: 15, Issue:12

    Topics: Adenoviridae Infections; Animals; Antineoplastic Agents; Antiviral Agents; Arabinose; Carbodiimides; Cyclic AMP; Cytarabine; Cytosine Nucleotides; Eye Diseases; Herpes Simplex; Kidney; Leukemia L1210; Mice; Myxoma; Nucleotides; Phosphoric Diester Hydrolases; Pseudorabies; Pyrimidine Nucleotides; Rabbits; Uracil Nucleotides; Vaccinia

1972
Virus diseases.
    The Practitioner, 1974, Volume: 213, Issue:1276 SPEC

    Topics: Amantadine; Chickenpox; Cytarabine; Cytomegalovirus; DNA Viruses; Eye Diseases; Female; Genital Diseases, Male; Gingivitis, Necrotizing Ulcerative; Herpes Zoster; Herpesviridae Infections; Humans; Idoxuridine; Influenza, Human; Male; Nails; Penicillins; Poxviridae Infections; Respiratory Tract Infections; Simplexvirus; Streptococcal Infections; Thiosemicarbazones; Urologic Diseases; Vaccination; Virus Diseases

1974